Clinical trial
ABT-751 in Treating Patients With Metastatic Prostate Cancer That Did Not…
NCT00471718 · Vanderbilt-Ingram Cancer Center, Other · Terminated
Key facts
| NCT number | NCT00471718 |
|---|---|
| Title | ABT-751 in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy |
| Official title | A Phase1/2 Trial of ABT-751 in Patients With Advanced, Androgen-Independent Prostate Cancer |
| Lead sponsor | Vanderbilt-Ingram Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Terminated |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Drug |
| Interventions | ABT-751 |
| Enrollment | 27 |
| Start date | Jan 1, 2004 |
| Primary completion | Aug 1, 2009 |
| Completion | Aug 1, 2009 |
| First posted | May 10, 2007 |
| Last update posted | Jul 11, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: